Biotech

All Articles

F 2G raises $100M for second effort to acquire new antifungal to market

.After F2G's 1st attempt to receive a brand-new training class of antifungal to market was actually ...

Moderna targets $1.1 B in R&ampD spending cuts, falls 5 courses amidst profits pressures

.Moderna has actually pledged to reduce R&ampD investing through $1.1 billion through 2027. The deci...

Sanofi's $80M bet on Key dystrophy drug finishes in period 3 go belly up

.Just four months after Sanofi bet $80 thousand in upfront cash on Fulcrum Rehabs' losmapimod, the p...

Oncternal assets sinks 60% in the middle of unemployments, test firings

.Cancer firm Oncternal Therapeutics is actually folding all its scientific trials and also giving up...

Roche is carrying out chances that its injectable weight problems possibility could eventually illustrate 25% weight loss in late-stage test

.Roche is actually storing out chances that its own injectable being overweight prospect can inevita...

Novo Nordisk barrages 'amazing' weight management result for dual-acting oral medicine in early test

.Novo Nordisk has elevated the cover on a phase 1 trial of its dental amylin as well as GLP-1 recept...

AbbVie files a claim against BeiGene over blood cancer drug classified information

.Only a handful of brief weeks after gaining an FDA Fast lane tag for its own investigational BTK de...

Lilly supplies one-two hit along with second tranche of positive data on regular blood insulin prospect

.Quickly after a good information decline for Eli Lilly's efsitora alfa, the Indianapolis-based prov...

BridgeBio cuts genetics therapy finances as scientific data dissatisfy

.BridgeBio Pharma is lowering its gene treatment finances and drawing back coming from the modality ...

GSK relinquishes HSV injection hopes after stage 2 fail, transferring race to Moderna, BioNTech

.GSK's effort to build the initial vaccination for herpes simplex infection (HSV) has finished in fa...